| Original language | English (US) |
|---|---|
| Pages (from-to) | 443-444 |
| Number of pages | 2 |
| Journal | JAMA - Journal of the American Medical Association |
| Volume | 324 |
| Issue number | 5 |
| Early online date | Jul 13 2020 |
| DOIs |
|
| State | Published - Aug 4 2020 |
Bibliographical note
Funding Information:receiving nonfinancial support from Alkermes; grants from the NIH (National Institute on Drug Abuse, National Institute on Alcohol Abuse and Alcoholism), the Patient-Centered Outcomes Research Institute (PCORI) via Philadelphia College of Osteopathic Medicine, PCORI via Public Health Management Corporation, Burroughs Wellcome Fund, and McLean Hospital; personal fees from the American Society of Addiction Medicine, National Council on Behavioral Healthcare, Leed Management Consulting Inc, Kaiser Permanente, UpToDate/Wolters Kluwer, Massachusetts Medical Society, Yale University, Group Health Inc, Charles University, National Committee on Quality Assurance, University of Oregon, Brandeis University, Karolinska Institutet, American Academy of Addiction Psychiatry, Partners, and Harvard Medical School; serving as president of the International Society of Addiction Journal Editors; editor of a book published by Springer; editor in chief of Journal of Addiction Medicine; serving on the editorial board of Journal of Addictive Diseases and Addiction Science & Clinical Practice; serving as an expert witness in malpractice cases related to alcohol and other drug use disorders; and consulting for CheckUp & Choices and ABT Corporation (not remunerated). Mr Schwitzer reported no disclosures.
Keywords
- Coronavirus
- COVID-19
- science communication